{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:17:25Z","timestamp":1778631445261,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2022J018"],"award-info":[{"award-number":["2022J018"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22037003"],"award-info":[{"award-number":["22037003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071446"],"award-info":[{"award-number":["32071446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204197"],"award-info":[{"award-number":["82204197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013385","name":"12th Five Year Plan for National Science and Technology Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0119000"],"award-info":[{"award-number":["2023YFE0119000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506402"],"award-info":[{"award-number":["2023YFC2506402"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFF1205104"],"award-info":[{"award-number":["2023YFF1205104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117258","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T20:21:25Z","timestamp":1736454085000},"page":"117258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of CZY43 as a new small-molecule degrader of pseudokinase HER3"],"prefix":"10.1016","volume":"285","author":[{"given":"Zhiyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-812X","authenticated-orcid":false,"given":"Ke","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117258_bib1","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1158\/1078-0432.CCR-20-4465","article-title":"Thirty years of HER3: from basic biology to therapeutic interventions","volume":"27","author":"Haikala","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117258_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.117258_bib3","doi-asserted-by":"crossref","first-page":"21608","DOI":"10.1073\/pnas.0912101106","article-title":"Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3","volume":"106","author":"Jura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117258_bib4","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.91.17.8132","article-title":"Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity","volume":"91","author":"Guy","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117258_bib5","first-page":"501","article-title":"Prospects for pharmacological targeting of pseudokinases","volume":"18","author":"Kung","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117258_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117258_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/djs501","article-title":"HER3 overexpression and survival in solid tumors: a meta-analysis","volume":"105","author":"Ocana","year":"2013","journal-title":"J. Natl. Cancer I."},{"key":"10.1016\/j.ejmech.2025.117258_bib8","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-08-0380","article-title":"A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy","volume":"68","author":"Lee-Hoeflich","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117258_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/0008-5472.CAN-12-1611","article-title":"Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117258_bib10","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1073\/pnas.1537685100","article-title":"The ErbB2\/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation","volume":"100","author":"Holbro","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117258_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12575-019-0093-1","article-title":"Development of effective therapeutics targeting HER3 for cancer treatment","volume":"21","author":"Liu","year":"2019","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.ejmech.2025.117258_bib12","first-page":"355","article-title":"HER3 signaling and targeted therapy in cancer","volume":"12","author":"Mishra","year":"2018","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.ejmech.2025.117258_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.01.005","article-title":"HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting","volume":"143","author":"Kol","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117258_bib14","doi-asserted-by":"crossref","first-page":"13225","DOI":"10.1073\/pnas.1518361112","article-title":"Inhibition of ErbB3 by a monoclonal antibody that locks the extracellular domain in an inactive configuration","volume":"112","author":"Lee","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117258_bib15","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911498","article-title":"HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies","volume":"12","author":"Gandullo-S\u00e1nchez","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117258_bib16","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.bmcl.2015.04.103","article-title":"Development of small molecules targeting the pseudokinase Her3","volume":"25","author":"Lim","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117258_bib17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nchembio.1658","article-title":"Pharmacological targeting of the pseudokinase Her3","volume":"10","author":"Xie","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117258_bib18","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1042\/BCJ20200496","article-title":"A small molecule inhibitor of HER3: a proof-of-concept study","volume":"477","author":"Colomba","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117258_bib19","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1021\/acs.jmedchem.3c00736","article-title":"Small-molecule hydrophobic tagging: a promising strategy of druglike technology for targeted protein degradation","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117258_bib20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117258_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32271","article-title":"Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface","volume":"7","author":"Claus","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2025.117258_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303934","article-title":"Inhibiting HER3 hyperphosphorylation in HER2-overexpressing breast cancer through multimodal therapy with branched gold nanoshells","volume":"19","author":"Villar-Alvarez","year":"2023","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.ejmech.2025.117258_bib23","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1535-7163.MCT-10-0019","article-title":"ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells","volume":"9","author":"Nautiyal","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2025.117258_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jtho.2019.09.195","article-title":"Inhibiting pathways predicted from a steroid hormone gene signature yields synergistic antitumor effects in NSCLC","volume":"15","author":"Almotlak","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejmech.2025.117258_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.597","article-title":"Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins","volume":"7","author":"Neklesa","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117258_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1080\/15548627.2022.2111083","article-title":"The role of LC3B in autophagy as an RNA-binding protein","volume":"19","author":"Hwang","year":"2023","journal-title":"Autophagy"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:42:11Z","timestamp":1778629331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"alternative-id":["S0223523425000236"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117258","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of CZY43 as a new small-molecule degrader of pseudokinase HER3","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117258"}}